Expanding bispecific antibody access for multiple myeloma involves collaboration between academic centers and community ...

At ASH 2025, iMMagine-1 data showed that anito-cel has a favorable and durable safety profile with low rates of severe CRS, neurotoxicity, and infections.

Incidence of venous thromboembolism remains 'substantial' despite expert guidelines and newer risk prediction scores ...

Patients share their unexpected journeys with multiple myeloma, revealing challenges and resilience in the face of a cancer ...

Multiple myeloma is a chronic (long-term) blood cancer that affects plasma cells made in the bone marrow, which is spongy tissue found inside bones. While people with multiple myeloma can live for ...

Johnson & Johnson has reported groundbreaking results from the phase 3 MajesTEC-3 study, highlighting the potential of TECVAYLI (teclistamab) combined with DARZALEX subcutaneous (daratumumab SC) as ...

Researchers at the Indiana University Melvin and Bren Simon Comprehensive Cancer Center have uncovered biological differences ...

Multiple myeloma is a rare blood cancer of the plasma cells in bone marrow -- the soft, spongy interior of bone where all blood cells are produced. Plasma cells are a type of white blood cell that ...

How Does Darzalex Faspro Work for Multiple Myeloma? Darzalex Faspro is a type of medicine called a monoclonal antibody that is also known as a targeted therapy or an immunotherapy. It works by ...

The National Comprehensive Cancer Network's Oncology Research Program selects projects to evaluate the effectiveness of elranatamab in the treatment of multiple myeloma. "Their research will help ...

Every year, an estimated 932 Filipinos are diagnosed with multiple myeloma, a cancer of the blood that develops in plasma cells found in the bone marrow. Plasma cells are a type of white blood cell ...